BCC Reports $5.1 Million Revenue in Q1 – New Cannabis Ventures

Visit the Canadian Bioceutical Corp Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

BCC Reports Q1 Fiscal 2018 Results

TORONTO, Sept. 28, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) reported its financial results for the first quarter of fiscal 2018, ended June 30, 2017.

... read more at: https://www.newcannabisventures.com/bcc-reports-5-1-million-revenue-in-q1/